Our findings suggest that the NF-κB, p38 MAPK, and PKC signal pathways are partially involved in the upregulation of KATP subunits Kir6.2/SUR1 expression induced by Aβ<sub>1-42</sub> cytotoxicity in neurons, which supports a potential theoretical basis of targeting these signal pathways in the treatment of AD.